NEW PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 18435 | Ritlecitinib ( PF-06651600 ) | 1792180-81-4 | ≧98.0% | _1792180-81-4.png) |
| Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a | ||||
| 20449 | Ervogastat (PF-06865571) | 2186700-33-2 | ≧98.0% | _2186700-33-2.png) |
| Ervogastat (PF-06865571), a systemically acting diacylglycerol acyltransferase (DGAT2 | ||||
| 171680 | Bexotegrast ( PLN-74809 ) | 2376257-44-0 | ≧98.0% | .png) |
| Bexotegrast (Synonyms: PLN-74809) is a small-molecule, dual selective inhibitor of α | ||||
| 20642 | OATD-02 | 2146132-73-0 | ≧98.0% |  |
| OATD-02, an orally available dual arginase inhibitor (ARG1 and ARG2), is in phase I c | ||||
| 20641 | KP-302 ( Synonyms: Lucid-21-302 ; Lucid-MS ) | 2082765-42-0 | ≧98.0% | _2082765-42-0.png) |
| KP-302 ( Synonyms: Lucid-21-302 ; Lucid-MS ) is a small molecule inhibitor of protein | ||||
| 20640 | FLAG-003 | 1614235-14-1 | ≧98.0% |  |
| FLAG-003 is a multi-acting, water-soluable small molecule therapeutic designed to tar | ||||
| 20639 | SOP1812 (QN-302) | 2546091-70-5 | ≧98.0% | _2546091-70-5.png) |
| QN-302 is a G-quadruplex (G4)-selective transcription inhibitor. | ||||
| 20618 | Pirtobrutinib | 2101700-15-4 | 98% Min. |  |
| 20576 | STX-721 | 2765525-82-2 | ≧98.0% |  |
| STX-721 is a next-generation, orally delivered therapy, designed with potential best- | ||||
| 611902 | PF-04979064 | 1220699-06-8 | ≧98.0% |  |
| PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with an IC(50) | ||||
| 52021 | Ganetespib(STA-9090) | 888216-25-9 | 98% |  |
| Ganetespib blocked the ability of HSP90 to bind to biotinylated geldanamycin and disr | ||||
| 20523 | 1-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE | 304903-10-4 | 98% Min. |  |